Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium
- PMID: 10589743
Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium
Comment on
-
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.Clin Cancer Res. 1999 Nov;5(11):3394-402. Clin Cancer Res. 1999. PMID: 10589750 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources